Clinical trial Recruiting at 1 site Observational Ages 18 and up

AI-assisted diagnosis of colorectal tubular adenomas using white-light, magnifying chromoendoscopy (including NBI) and pathology images

Official title: Development and Demonstration of a Precision Prevention and Treatment System for Colorectal Tubular Adenomas Lesions

Run by Renmin Hospital of Wuhan University · NCT07073430 · Data updated 2026-11-12

This project will test whether an AI tool that combines white-light, magnified chromoendoscopy, NBI, and pathology images can help doctors identify colorectal tubular adenomas in adults undergoing colonoscopy.

More Artificial Intelligence (AI) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment4000 (estimated)
SponsorRenmin Hospital of Wuhan University
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedNovember 28, 2023
Main results expectedOctober 31, 2026
Study endsOctober 31, 2026
Registry record updatedOctober 1, 2026
Trial IDNCT07073430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are scheduled for colonoscopy, can give informed consent, and can complete standard bowel preparation are ideal candidates.

Probably not a fit

Patients with prior abdominal or pelvic surgery or radiotherapy, active lower gastrointestinal bleeding, hereditary polyposis or inflammatory bowel disease, uncontrolled cardiovascular conditions, pregnancy, or inability to complete bowel preparation are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multi-center observational project will build a matched "trinity" database of white-light endoscopy, magnifying chromoendoscopy (including NBI), and corresponding pathological images of colorectal tubular adenomas. Investigators will apply the previously proposed multimodal endoscopic LAFEQ approach to train deep-learning diagnostic models and to create an interpretable risk-prediction model for adenomas. Models will be validated across participating hospitals to measure diagnostic accuracy and the transparency of the model's decision basis. Patients will receive standard-of-care colonoscopy and pathology; collected imaging and pathology data will be used for model development and evaluation.

Why it matters

Potential benefit: If successful, the tool could help clinicians detect and characterize adenomas more accurately and provide clear, interpretable reasons for its recommendations, potentially improving diagnosis and treatment decisions.

How similar studies have gone: Prior AI research for polyp detection and characterization has shown promising accuracy, but fully multimodal and interpretable systems like this are relatively novel and not yet widely validated in large prospective multicenter cohorts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged ≥ 18 years, who need to undergo colonoscopy, regardless of gender.
* Voluntarily sign the informed consent form
* Promise to abide by the research procedures and cooperate in the implementation of the entire research process.

Exclusion Criteria:

* Patients who has a history of abdominal or pelvic surgery or radiotherapy in the past;
* Patients who has definite active lower gastrointestinal bleeding.
* Existing or suspected hereditary colorectal polyposis, inflammatory bowel disease;
* Uncontrolled hypertension (systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 95 mmHg after standardized treatment)
* There is a history of stroke, coronary artery disease, or vascular disease;
* Pregnant;
* Intestinal preparation cannot be carried out.

Where it's running

  • Renmin Hospital of Wuhan University
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.